nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—OPRM1—nicotine dependence	0.542	0.646	CbGaD
Ketamine—DRD2—nicotine dependence	0.297	0.354	CbGaD
Ketamine—GRIN1—midbrain—nicotine dependence	0.00221	0.0929	CbGeAlD
Ketamine—GRIN2A—midbrain—nicotine dependence	0.00184	0.0775	CbGeAlD
Ketamine—GRIN2C—brain—nicotine dependence	0.00168	0.0704	CbGeAlD
Ketamine—GRIN2D—brain—nicotine dependence	0.00156	0.0655	CbGeAlD
Ketamine—GRIN3A—brain—nicotine dependence	0.00147	0.0616	CbGeAlD
Ketamine—GRIN1—brain—nicotine dependence	0.00139	0.0584	CbGeAlD
Ketamine—GRIN2B—brain—nicotine dependence	0.00133	0.0557	CbGeAlD
Ketamine—TACR1—brain—nicotine dependence	0.00127	0.0534	CbGeAlD
Ketamine—GRIN2A—brain—nicotine dependence	0.00116	0.0487	CbGeAlD
Ketamine—OPRM1—midbrain—nicotine dependence	0.00112	0.0471	CbGeAlD
Ketamine—OPRD1—brain—nicotine dependence	0.00103	0.0434	CbGeAlD
Ketamine—OPRK1—brain—nicotine dependence	0.00099	0.0416	CbGeAlD
Ketamine—GRIN2C—Neuronal System—CHRNA6—nicotine dependence	0.000889	0.00654	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000885	0.00652	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNB3—nicotine dependence	0.000871	0.00642	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000852	0.00627	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000839	0.00617	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNA6—nicotine dependence	0.000826	0.00608	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000816	0.00601	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000815	0.006	CbGpPWpGaD
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00081	0.00597	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000804	0.00592	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000794	0.00585	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00078	0.00574	CbGpPWpGaD
Ketamine—CYP2B6—cardiovascular system—nicotine dependence	0.000775	0.0325	CbGeAlD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000772	0.00569	CbGpPWpGaD
Ketamine—CYP2C9—cardiovascular system—nicotine dependence	0.000767	0.0322	CbGeAlD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000759	0.00559	CbGpPWpGaD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000753	0.00555	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000753	0.00554	CbGpPWpGaD
Ketamine—DRD2—midbrain—nicotine dependence	0.000748	0.0314	CbGeAlD
Ketamine—GRIN2C—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000747	0.0055	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000747	0.0055	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000743	0.00547	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000724	0.00533	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNB3—nicotine dependence	0.000716	0.00527	CbGpPWpGaD
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000713	0.00525	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000712	0.00524	CbGpPWpGaD
Ketamine—OPRM1—brain—nicotine dependence	0.000705	0.0296	CbGeAlD
Ketamine—PTGS1—cardiovascular system—nicotine dependence	0.0007	0.0294	CbGeAlD
Ketamine—GRIN2D—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000695	0.00512	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000694	0.00511	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNA6—nicotine dependence	0.000678	0.005	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000669	0.00492	CbGpPWpGaD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000663	0.00488	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000662	0.00487	CbGpPWpGaD
Ketamine—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000661	0.00487	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000653	0.00481	CbGpPWpGaD
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000648	0.00477	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000645	0.00475	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—GABRA4—nicotine dependence	0.000642	0.00473	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00064	0.00471	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000632	0.00465	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNB3—nicotine dependence	0.000624	0.0046	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000622	0.00458	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000619	0.00456	CbGpPWpGaD
Ketamine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000616	0.00454	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—CHRNB4—nicotine dependence	0.000616	0.00454	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000614	0.00452	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000609	0.00449	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNB3—nicotine dependence	0.000608	0.00448	CbGpPWpGaD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000602	0.00443	CbGpPWpGaD
Ketamine—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000599	0.00441	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—GABRA4—nicotine dependence	0.000597	0.0044	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNA6—nicotine dependence	0.000592	0.00436	CbGpPWpGaD
Ketamine—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.00058	0.00427	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNA6—nicotine dependence	0.000577	0.00425	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000574	0.00423	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—CHRNA5—nicotine dependence	0.000573	0.00422	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNB4—nicotine dependence	0.000573	0.00422	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000571	0.0042	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000566	0.00417	CbGpPWpGaD
Ketamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000563	0.00415	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000558	0.00411	CbGpPWpGaD
Ketamine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000556	0.00409	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000552	0.00406	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000546	0.00402	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000545	0.00401	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000544	0.00401	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00054	0.00397	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000536	0.00395	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000535	0.00394	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNA5—nicotine dependence	0.000532	0.00392	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000526	0.00387	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000522	0.00384	CbGpPWpGaD
Ketamine—SLC6A2—brain—nicotine dependence	0.000516	0.0217	CbGeAlD
Ketamine—GRIN2D—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000499	0.00367	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000498	0.00366	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000495	0.00364	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—GABRA4—nicotine dependence	0.00049	0.00361	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000487	0.00359	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000485	0.00357	CbGpPWpGaD
Ketamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000477	0.00351	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000475	0.0035	CbGpPWpGaD
Ketamine—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000471	0.00347	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNB4—nicotine dependence	0.00047	0.00346	CbGpPWpGaD
Ketamine—DRD2—brain—nicotine dependence	0.00047	0.0197	CbGeAlD
Ketamine—GRIN2C—Neuronal System—CHRNA3—nicotine dependence	0.000467	0.00344	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000465	0.00342	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000463	0.00341	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000461	0.00339	CbGpPWpGaD
Ketamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000457	0.00336	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000453	0.00333	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNA5—nicotine dependence	0.000437	0.00322	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000436	0.00321	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNA3—nicotine dependence	0.000434	0.0032	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000431	0.00318	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—GABRA4—nicotine dependence	0.000428	0.00315	CbGpPWpGaD
Ketamine—CYP2C8—brain—nicotine dependence	0.000424	0.0178	CbGeAlD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000421	0.0031	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—GABRA4—nicotine dependence	0.000417	0.00307	CbGpPWpGaD
Ketamine—ABCB1—cardiovascular system—nicotine dependence	0.000414	0.0174	CbGeAlD
Ketamine—GRIN2C—Neuronal System—CHRNB2—nicotine dependence	0.000411	0.00303	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNB4—nicotine dependence	0.00041	0.00302	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000409	0.00302	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000406	0.00299	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNB4—nicotine dependence	0.0004	0.00294	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000396	0.00291	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000395	0.00291	CbGpPWpGaD
Ketamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000388	0.00286	CbGpPWpGaD
Ketamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000387	0.00285	CbGpPWpGaD
Ketamine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000383	0.00282	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNB2—nicotine dependence	0.000382	0.00281	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNA5—nicotine dependence	0.000381	0.00281	CbGpPWpGaD
Ketamine—CYP2B6—brain—nicotine dependence	0.00038	0.016	CbGeAlD
Ketamine—TACR1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000378	0.00278	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000377	0.00277	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—CHRNA4—nicotine dependence	0.000373	0.00275	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000372	0.00274	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNA5—nicotine dependence	0.000372	0.00274	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00037	0.00273	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000357	0.00263	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNA3—nicotine dependence	0.000356	0.00262	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000349	0.00257	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000348	0.00256	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—CHRNA4—nicotine dependence	0.000347	0.00255	CbGpPWpGaD
Ketamine—PTGS1—brain—nicotine dependence	0.000344	0.0144	CbGeAlD
Ketamine—TACR1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000343	0.00253	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00033	0.00243	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000324	0.00239	CbGpPWpGaD
Ketamine—ABCB1—midbrain—nicotine dependence	0.000323	0.0136	CbGeAlD
Ketamine—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.000318	0.00234	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000316	0.00233	CbGpPWpGaD
Ketamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000315	0.00232	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNB2—nicotine dependence	0.000314	0.00231	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000311	0.00229	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNA3—nicotine dependence	0.000311	0.00229	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNA3—nicotine dependence	0.000303	0.00223	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—FGD1—nicotine dependence	0.000297	0.00218	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—CHRNA4—nicotine dependence	0.000285	0.0021	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—OPRM1—nicotine dependence	0.000282	0.00208	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000279	0.00206	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNB2—nicotine dependence	0.000274	0.00201	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000273	0.00201	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—FGD1—nicotine dependence	0.000269	0.00198	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000268	0.00197	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNB2—nicotine dependence	0.000267	0.00196	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000262	0.00193	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000257	0.00189	CbGpPWpGaD
Ketamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000256	0.00188	CbGpPWpGaD
Ketamine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000253	0.00186	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—CHRNA4—nicotine dependence	0.000248	0.00183	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000243	0.00179	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000243	0.00179	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—CHRNA4—nicotine dependence	0.000242	0.00178	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000239	0.00176	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00023	0.00169	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000218	0.0016	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000213	0.00157	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000213	0.00157	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000212	0.00156	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000209	0.00154	CbGpPWpGaD
Ketamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000208	0.00153	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000205	0.00151	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—DRD2—nicotine dependence	0.000204	0.0015	CbGpPWpGaD
Ketamine—ABCB1—brain—nicotine dependence	0.000203	0.00853	CbGeAlD
Ketamine—TACR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000203	0.00149	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000203	0.00149	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000193	0.00142	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00019	0.0014	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000187	0.00137	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000183	0.00135	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000177	0.00131	CbGpPWpGaD
Ketamine—Nystagmus—Varenicline—nicotine dependence	0.000176	0.198	CcSEcCtD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000176	0.0013	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00017	0.00125	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000167	0.00123	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000167	0.00123	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000166	0.00122	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000165	0.00121	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000163	0.0012	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000159	0.00117	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FGD1—nicotine dependence	0.000159	0.00117	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000159	0.00117	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000158	0.00116	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000154	0.00114	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000152	0.00112	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000151	0.00111	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000148	0.00109	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000147	0.00108	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000146	0.00108	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—OPRM1—nicotine dependence	0.000145	0.00107	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000143	0.00105	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKR1B10—nicotine dependence	0.000141	0.00103	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000141	0.00103	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000139	0.00103	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000137	0.00101	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.000979	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000132	0.000973	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00013	0.00096	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000124	0.000912	CbGpPWpGaD
Ketamine—Salivary hypersecretion—Varenicline—nicotine dependence	0.000122	0.137	CcSEcCtD
Ketamine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00012	0.00088	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000117	0.000862	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000117	0.000861	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—DRD2—nicotine dependence	0.000115	0.000848	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000115	0.000845	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000114	0.000841	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000112	0.000828	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000112	0.000823	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00011	0.000812	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000109	0.0008	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000109	0.000799	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DRD2—nicotine dependence	0.000105	0.00077	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000741	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000737	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—WASF2—nicotine dependence	9.9e-05	0.000729	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—WASF1—nicotine dependence	9.49e-05	0.000699	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	9.38e-05	0.000691	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8.97e-05	0.000661	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FGD1—nicotine dependence	8.96e-05	0.00066	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	8.92e-05	0.000657	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—OPRM1—nicotine dependence	8.55e-05	0.000629	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	8.52e-05	0.000627	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	8.51e-05	0.000626	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	8.46e-05	0.000623	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	8.15e-05	0.0006	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.92e-05	0.000583	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	7.87e-05	0.000579	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGD1—nicotine dependence	7.86e-05	0.000579	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	7.15e-05	0.000526	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	6.94e-05	0.000511	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGD1—nicotine dependence	6.64e-05	0.000489	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	6.53e-05	0.000481	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	6.49e-05	0.000478	CbGpPWpGaD
Ketamine—Bradycardia—Varenicline—nicotine dependence	6.43e-05	0.0721	CcSEcCtD
Ketamine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	6.41e-05	0.000472	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD2—nicotine dependence	6.18e-05	0.000455	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	5.89e-05	0.000434	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	5.87e-05	0.000432	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	5.69e-05	0.000419	CbGpPWpGaD
Ketamine—Arrhythmia—Varenicline—nicotine dependence	5.64e-05	0.0633	CcSEcCtD
Ketamine—OPRD1—Signaling Pathways—WASF2—nicotine dependence	5.58e-05	0.000411	CbGpPWpGaD
Ketamine—Erythema—Varenicline—nicotine dependence	5.5e-05	0.0617	CcSEcCtD
Ketamine—PTGS1—Metabolism—CYP2A7—nicotine dependence	5.44e-05	0.0004	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—WASF1—nicotine dependence	5.35e-05	0.000394	CbGpPWpGaD
Ketamine—Vision blurred—Varenicline—nicotine dependence	5.18e-05	0.0581	CcSEcCtD
Ketamine—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	5.17e-05	0.00038	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.04e-05	0.000371	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.03e-05	0.000371	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—WASF2—nicotine dependence	4.89e-05	0.00036	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	4.81e-05	0.000354	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	4.81e-05	0.000354	CbGpPWpGaD
Ketamine—Convulsion—Varenicline—nicotine dependence	4.76e-05	0.0534	CcSEcCtD
Ketamine—OPRK1—Signaling Pathways—WASF1—nicotine dependence	4.69e-05	0.000345	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	4.58e-05	0.000337	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	4.45e-05	0.000327	CbGpPWpGaD
Ketamine—Shock—Varenicline—nicotine dependence	4.41e-05	0.0495	CcSEcCtD
Ketamine—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	4.37e-05	0.000321	CbGpPWpGaD
Ketamine—Anorexia—Varenicline—nicotine dependence	4.28e-05	0.048	CcSEcCtD
Ketamine—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	4.22e-05	0.000311	CbGpPWpGaD
Ketamine—Hypotension—Varenicline—nicotine dependence	4.19e-05	0.047	CcSEcCtD
Ketamine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	4.15e-05	0.000305	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—WASF2—nicotine dependence	4.13e-05	0.000304	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—WASF1—nicotine dependence	3.96e-05	0.000292	CbGpPWpGaD
Ketamine—Decreased appetite—Varenicline—nicotine dependence	3.9e-05	0.0438	CcSEcCtD
Ketamine—Pain—Varenicline—nicotine dependence	3.84e-05	0.043	CcSEcCtD
Ketamine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	3.51e-05	0.000259	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD2—nicotine dependence	3.48e-05	0.000256	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.13e-05	0.000231	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.06e-05	0.000225	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.05e-05	0.000225	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3e-05	0.000221	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	2.86e-05	0.00021	CbGpPWpGaD
Ketamine—Vomiting—Varenicline—nicotine dependence	2.85e-05	0.032	CcSEcCtD
Ketamine—Rash—Varenicline—nicotine dependence	2.83e-05	0.0317	CcSEcCtD
Ketamine—Dermatitis—Varenicline—nicotine dependence	2.83e-05	0.0317	CcSEcCtD
Ketamine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.7e-05	0.000199	CbGpPWpGaD
Ketamine—Nausea—Varenicline—nicotine dependence	2.66e-05	0.0299	CcSEcCtD
Ketamine—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.58e-05	0.00019	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.89e-05	0.000139	CbGpPWpGaD
